Merck & Co is a general drug manufacturer company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker MRK on the NYSE exchange.
Merck & Co stock last closed at $108.18, down 0.92% from the previous day, and has increased 11.95% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.19 percentage points. Merck & Co stock is currently +47.57% from its 52-week low of $73.31, and -4.18% from its 52-week high of $112.90.
As of Jan 23, 2026, there are 2.48B MRK shares outstanding. The market cap of MRK is $268.51B. In the past 24 hours, 10.49M MRK shares were traded.
You need a brokerage account in order to access the NYSE market and buy MRK shares.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal details so you are able to invest in MRK today.
Now that you've opened your account on the best app for stock investing, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new brokerage account.
After you have figured out the best place to buy Merck & Co stock, it's critical to research their stock before you buy, so you can comprehend the risk and opportunity.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on MRK's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge MRK's true value.
Using relative valuations ratios:
You can do additional valuation research on MRK's stock here.
Out of 11 sell side analysts who give ratings on MRK, the consensus analyst rating on Merck & Co is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Tim Anderson, a top 19% analyst from Bank of America maintains MRK with a strong buy rating and raises their MRK price target from $105.00 to $120.00, on Dec 15, 2025.
Bank of America's Tim Anderson raised their price target on Merck & Co (NYSE: MRK) by 14.3% from $105 to $120 on 2025/12/15. The analyst maintained their Strong Buy rating on the stock.
Hiking their price target on Merck & Co., Anderson said they shifted their valuation basis to their FY 2027 estimates.
The analyst added that the stock "looks attractive" because the company has "rounded out" its pipeline.
Terence Flynn, a top 5% analyst from Morgan Stanley maintains MRK with a hold rating and raises their MRK price target from $100.00 to $102.00, on Dec 12, 2025.
Louise Chen, a top 18% analyst from ScotiaBank maintains MRK with a buy rating and raises their MRK price target from $105.00 to $120.00, on Dec 4, 2025.
Mohit Bansal, a top 14% analyst from Wells Fargo upgrades MRK to a strong buy rating and raises their MRK price target from $90.00 to $125.00, on Nov 24, 2025.
James Shin, a top 30% analyst from Deutsche Bank maintains MRK with a hold rating and raises their MRK price target from $110.00 to $111.00, on Nov 18, 2025.
You can dig deeper into what analysts are projecting on the Merck & Co stock forecast page.
Last year, MRK earnings were $19.03B. Over the last five year, MRK's earnings have increased by 10.72% per year. This was slower than the Drug Manufacturers - General industry average of 11.93%.
Last year, MRK revenue was $64.24B. Over the past 5 year, MRK's revenue has grown by 11.98% per year. This was faster than the Drug Manufacturers - General industry average of 10.84%.
You can research MRK's earnings and revenue performance here.
In the past year, insiders at MRK have bought more shares than they have sold.
Cristal N. Downing, Chief Comm. Public Afrs Ofcr of MRK, was the latest MRK insider to sell. They sold $616,395.00 worth of MRK shares on Nov 10, 2025.
Get more info about who owns MRK stock here.
Merck & Co pays a dividend of 3.03%, compared to the Drug Manufacturers - General industry's average dividend yield of 2.75%. If you owned $1,000 of MRK stock, you would have received $30.32 last year.
Merck & Co dividend payments have consistently grown over the past decade and have remained stable.
Dig into more data about Merck & Co dividend yield and history here.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Click the Open button and eToro will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in MRK, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to track the latest developments regarding your MRK stock.
To summarize, here are the 6 steps you need to take to buy Merck & Co stock right now:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Merck & Co, click the button below.